⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ABBV

AbbVie Inc.

Healthcare · Drug Manufacturers - General

250.91USD

+2.1300 (+0.86%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 250.91
P/E70.3
Dvd Ind Yld2.8%
P/B—
P/S6.9
Curr EV/T12M EBITDA28.8
Mkt Cap (USD)443.4B
Curr EV (USD)507.8B
2)

Per Share Data

EPS T12M3.54
DPS6.76
Bk Val Per Sh-3.36
Rev/Sh36.36
Cash/Sh3.72
Curr Shares Out1,767.1M
FCF/Sh10.28
3)

Cash Flow Analysis

P/CF22.7
Curr P/FCF24.3
CF/NI3.1
Dvd P/O189.8%
Cash Gen/Cash Reqd1.5
Csh Dvd Cov1.6
CFO/Sales30.3%
Eff Interest Rate105.0%
4)

Growth Potential

Dil EPS 1Y Gr-1.3%
Cap 1Y Gr-9.2%
BPS 1Y Gr-198.3%
R&D To Sales—
Retention Rate-89.8%
Rev 1Y Gr8.6%
FCF 1Y Gr-0.1%
Assets 1Y Gr-0.9%
5)

Profitability

EBITDA17.6B
EBIT16.9B
Operating Margin26.2%
Pretax Margin13.5%
Net Margin9.8%
ROA4.6%
ROE-206.3%
ROC20.9%
Asset Turnover0.47
6)

Structure

Current Ratio0.81
Quick Ratio0.49
Debt/Assets47.7%
Debt/Com Eq-1086.8%
Net Debt/EBITDA3.28
Tot Debt/Capital110.1%
Gross Margin71.5%
EBIT/Int Exp5.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.